Brachial Artery Flow-Mediated Dilation and Asymmetrical Dimethylarginine in the Cardiovascular Risk in Young Finns Study
Data up to Jan 2025
Total Citations Per Year
Abstract
References (48)
Atherosclerosis — An Inflammatory Disease
1999 • 21,494 citations
Prediction of Creatinine Clearance from Serum Creatinine
1976 • 15,066 citations
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
1987 • 10,774 citations
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
1992 • 4,765 citations
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 • 3,669 citations
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
1992 • 2,138 citations
Close relation of endothelial function in the human coronary and peripheral circulations
1995 • 2,061 citations
Redefining Oxidative Stress
2006 • 1,587 citations
Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction
1998 • 1,182 citations
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
2001 • 1,076 citations
Endogenous Nitric Oxide Synthase Inhibitor
1999 • 775 citations
Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor
2002 • 590 citations
Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase Pathway
2004 • 551 citations
Interrelations Between Brachial Endothelial Function and Carotid Intima-Media Thickness in Young Adults
2004 • 429 citations
ADMA and oxidative stress
2003 • 420 citations
Determination of Arginine, Asymmetric Dimethylarginine, and Symmetric Dimethylarginine in Human Plasma and Other Biological Samples by High-Performance Liquid Chromatography
2002 • 417 citations
Cardiovascular Effects of Systemic Nitric Oxide Synthase Inhibition With Asymmetrical Dimethylarginine in Humans
2003 • 399 citations
Heterogenous Nature of Flow-Mediated Dilatation in Human Conduit Arteries In Vivo
2001 • 394 citations
Asymmetrical Dimethylarginine
2004 • 392 citations
Asymmetric Dimethylarginine and the Risk of Cardiovascular Events and Death in Patients With Coronary Artery Disease
2005 • 379 citations
Interference ofL-Arginine Analogues withL-Arginine Transport Mediated by the y+Carrier hCAT-2B
1997 • 374 citations
Symmetric dimethylarginine (SDMA) as endogenous marker of renal function—a meta-analysis
2006 • 339 citations
Dimethylarginine Dimethylaminohydrolase Regulates Nitric Oxide Synthesis
2003 • 339 citations
The Determinants of Endothelial Dysfunction in CKD: Oxidative Stress and Asymmetric Dimethylarginine
2005 • 323 citations
Symmetrical Dimethylarginine
2006 • 277 citations
Asymmetric Dimethylarginine, L-Arginine, and Endothelial Dysfunction in Essential Hypertension
2005 • 276 citations
Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine
2001 • 247 citations
Asymmetrical Dimethylarginine Independently Predicts Total and Cardiovascular Mortality in Individuals with Angiographic Coronary Artery Disease (The Ludwigshafen Risk and Cardiovascular Health Study)
2006 • 227 citations
Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase.
2001 • 225 citations
Asymmetric dimethylarginine (ADMA): A novel risk marker in cardiovascular medicine and beyond
2006 • 223 citations
ADMA Increases Arterial Stiffness and Decreases Cerebral Blood Flow in Humans
2006 • 212 citations
Asymmetric Dimethylarginine, Blood Pressure, and Renal Perfusion in Elderly Subjects
2003 • 208 citations
Brachial Flow-Mediated Vasodilator Responses in Population-Based Research: Methods, Reproducibility and Effects of Age, Gender and Baseline Diameter
2001 • 191 citations
Adverse Effects of Cigarette Smoke on NO Bioavailability
2006 • 170 citations
Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase
1995 • 160 citations
Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine
2004 • 145 citations
Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy.
2006 • 133 citations
Evaluation of endothelium‐dependent vasodilation in the human peripheral circulation
2000 • 96 citations
Endogenous Methylarginines Modulate Superoxide as Well as Nitric Oxide Generation from Neuronal Nitric-oxide Synthase
2004 • 95 citations
Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease
2005 • 91 citations
Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy
2003 • 89 citations
Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum
2005 • 62 citations
Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxide synthase
2006 • 56 citations
Insulin and adiponectin inhibit the TNFα-induced ADMA accumulation in human endothelial cells
2006 • 49 citations
Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemia
2006 • 48 citations
Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia
2002 • 48 citations
Inhibition of <scp>l</scp>‐arginine transport in platelets by asymmetric dimethylarginine and NG‐monomethyl‐<scp>l</scp>‐arginine: Effects of arterial hypertension
2004 • 35 citations
Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia
2007 • 35 citations